Abstract
Compelling evidence for the involvement in the neoplastic process of molecules regulating normal cellular growth originates from observations demonstrating that the transduced oncogenes of certain acute transforming retroviruses represent activated versions of growth factors or growth factor receptors. When incorporated within the retroviral genome, such transduced sequences acquire the ability to induce neoplastic transformation. Analysis of viral oncogene products has revealed important insights into the function of their normal cellular counterparts, designated protooncogenes. For example, in AEV-induced neoplasia, the EGF receptor gene (c-erbB) is activated as an oncogene (v-erbB) upon amino-terminal truncation of the coding sequence combined with other modifications [1]. This has been observed for two independent transductions of the c-erbB locus into acute transforming retroviruses [2, 3], as well as in c-erbB activation by promoter insertion during retroviral leukemogenesis [4]. The transforming gene of the feline sarcoma virus SM-FeSV represents another growth factor receptor tyrosine kinase, the CSF-1 receptor [5]. Oncogenic conversion by a retrovirus in this case (v-fms) involves more subtle structural alterations at the carboxyl terminus of the c-fms protooncogene [6].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Downward, J., Yarden, Y., Mayes, E., Scrace, G., Totty, N., Stockwell, P., Ullrich, A., Schlessinger, J., Waterfield, M.D. (1984) Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences. Nature 307:521–527.
Debuire, B., Henry, C., Bernissa, M., Biserte, G., Claverie, J.M., Saule, S., Martin, P., Stehelin, D. (1984) Sequencing the erbA gene of avian erythroblastosis virus reveals a new type of oncogene. Science 224:1456–1459.
Yamamoto, T., Nishida, T., Miyajima, N., Kawai, S., Ooi, T., Toyoshima, K. (1983) The erbB gene of avian erythroblastosis virus is a member of the src gene family. Cell 35:71–78.
Nilsen, T.W., Maroney, P.A., Goodwin, R.G., Rottman, F.M., Crittenden, L.B., Raines, M.A., Kung, H.J. (1985) c-erbB activation in ALV-induced erythroblastosis: Novel RNA processing and promoter insertion result in expression of an amino-truncated EGF receptor. Cell. 41:719–726.
Sherr, C.J., Rettenmier, C.W., Sacca, R., Roussel, M.F., Look, A.T., Stanley, E.R. (1985) The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1. Cell. 41:665–676.
Coussens, L., van, B.C., Smith, D., Chen, E., Mitchell, R.L., Isacke, C.M., Verma, I.M., Ullrich, A. (1986) Structural alteration of viral homologue of receptor proto-oncogene fms at carboxyl terminus. Nature 230:277–280.
Schechter, A.L., Stern, D.F., Vaidyanathan, L., Decker, S.J., Drebin, J.A., Greene, M.I., Weinberg, R.A. (1984) The neu oncogene: An erb-B-related gene encoding a 185,000-Mr tumour antigen. Nature 312:513–516.
Drebin, J.A., Stern, D.F., Link, V.C., Weinberg, R.A., Greene, M.I. (1984) Monoclonal antibodies identify a cell-surface antigen associated with an activated cellular oncogene. Nature 312:545–548.
Bargmann, C.I., Hung, M.C., Weinberg, R.A. (1986) Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Cell. 45:649–657.
Bargmann, C.I., Weinberg, R.A. (1988) Increased tyrosine kinase activity associated with the protein encoded by the activated neu oncogene. Proc. Natl. Acad. Sci. U.S.A. 85:5394–5398.
Ullrich, A., Coussens, K., Hayflick, J.S., Dull, T.J., Gray, A., Tarn, A.W., Lee, J., Yarden, Y., Libermann, T.A., Schlessinger, J., Downward, J., Mayes, E., Whittle, N., Waterfield, M.D., and Seeburg, P.H. (1984) Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 309:418–425.
Hanks, S.K., Quinn, A.M., Hunter, T. (1988) The protein kinase family: Conserved features and deduced phylogeny of the catalytic domains. Science 241:42–52.
Kraus, M.H., Aaronson, S.A. (1991) Detection of novel protein-tyrosine kinase genes employing reduced stringency hybridization. In: Hunter, T., Sefton, B.M., eds., Protein Phosphorylation. Academic Press, New York, Meth Enzymol 200, in press.
King, C.R., Kraus, M.H., Aaronson, S.A. (1985) Amplification of a novel v-erbB-related gene in a human mammary carcinoma. Science 229:974–976.
Kraus, M.H., Issing, W., Miki, T., Popescu, N.C., Aaronson, S.A. (1989) Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: Evidence for overexpression in a subset of human mammary tumors. Proc. Natl. Acad. Sci. U.S.A. 86:9193–9197.
Schechter, A.L., Hung, M.C., Vaidyanathan, L., Weinberg, R.A., Yang, F.T., Francke, U., Ullrich, A., Coussens, L. (1985) The neu gene: An erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor. Science 229:976–978.
Semba, K., Kamata, N., Toyoshima, K., Yamamoto, T. (1985) A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma. Proc. Natl. Acad. Sci. U.S.A. 82:6497–6501.
Coussens, L., Yang Feng, T.L., Liao, Y.C., Chen, E., Gray, A., McGrath, J., Seeburg, P.H., Libermann, T.A., Schlessinger, J., Francke, U., Levinson, A., Ullrich, A. (1985) Tyrosine kinase receptor with extensive homology of EGF receptor shares chromosomal location with neu oncogene. Science 230:1132–1139.
Plowman, G.D., Whitney, G.S., Neubauer, M.G., Green, J.M., McDonald, V.L., Todaro, G.J., Shoyab, M. (1990) Molecular cloning and expression of an additional epidermal growth factor receptor-related gene. Proc. Natl. Acad. Sci. U.S.A. 87:4905–4909.
Merlino, G.T., Ishii, S., Whang, P.J., Knutsen, T., Xu, Y.H., Clark, A., Stratton, R.H., Wilson, R.K., Ma, D.P., Roe, B.A., Hunts, J.H., Shimizu, N., Pastan, I. (1985) Structure and localization of genes encoding aberrant and normal epidermal growth factor receptor RNAs from A431 human carcinoma cells. Mol. Cell. Biol. 5:1722–1734.
Yamamoto, T., Ikawa, S., Akiyama, T., Semba, K., Nomura, N., Miyajima, N., Saito, T., Toyoshima, K. (1986) Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor. Nature 319:230–234.
Bargmann, C.I., Hung, M.C., Weinberg, R.A. (1986) The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature 319:226–230.
Xu, Y.H., Ishii, S., Clark, A.J., Sullivan, M., Wilson, R.K., Ma, D.P., Roe, B.A., Merlino, G.T., Pastan, I. (1984) Human epidermal growth factor receptor cDNA is homologous to a variety of RNAs overproduced in A431 carcinoma cells. Nature 309:806–810.
Ullrich, A., Schlessinger, J. (1990) Signal transduction by receptors with tyrosine kinase activity. Cell. 61:203–212.
Carpenter, G., Cohen, S. (1979) Epidermal growth factor. Annu. Rev. Biochem. 48:193–216.
Todaro, G.J., Fryling, C., De, L.J. (1980) Transforming growth factors produced by certain human tumor cells: Polypeptides that interact with epidermal growth factor receptors. Proc. Natl. Acad. Sci. U.S.A. 77:5258–5262.
Blomquist, M.C., Hunt, L.T., Barker, W.C. (1984) Vaccinia virus 19-kilodalton protein: Relationship to several mammalian proteins, including two growth factors. Proc. Natl. Acad. Sci. U.S.A. 81:7363–7367.
Shoyab, M., Plowman, G.D., McDonald, V.L., Bradley, J.G., Todaro, G.J. (1989) Structure and function of human amphiregulin: A member of the epidermal growth factor family. Science 243:1074–1076.
Yarden, Y., Weinberg, R.A. (1989) Experimental approaches to hypothetical hormones: Detection of a candidate ligand of the neu protooncogene. Proc. Natl. Acad. Sci. U.S.A. 86:3179–3183.
Lupu, R., Colomer, R., Zugmaier, G., Sarup, J., Shepard, M., Slamon, D., Lippman, M.E. (1990) Direct interaction of a ligand for the erbB2 oncogene product with the EGF receptor and p185erbB2. Science 249:1552–1555.
Ishii, S., Imamoto, F., Yamanashi, Y., Toyoshima, K., Yamamoto, T. (1987) Characterization of the promoter region of the human c-erbB-2 protooncogene. Proc. Natl. Acad. Sci. U.S.A. 84:4374–4378.
Sporn, M.B., Todaro, G.J. (1980) Autocrine secretion and malignant transformation of cells. N. Engl. J. Med. 303:878–880.
Rubin, J.S., Osada, H., Finch, P.W., Taylor, W.G., Rudikoff, S., Aaronson, S.A. (1989) Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 86:802–806.
Libermann, T.A., Nusbaum, H.R., Razon, N., Kris, R., Lax, I., Soreq, H., Whittle, N., Waterfield, M.D., Ullrich, A., Schlessinger, i. (1985) Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature 313:144–147.
Xu, Y.H., Richert, N., Ito, S., Merlino, G.T., Pastan, I. (1984) Characterization of epidermal growth factor receptor gene expression in malignant and normal human cell lines. Proc. Natl. Acad. Sci. U.S.A. 81:7308–7312.
Yamamoto, T., Kamata, N., Kawano, H., Shimizu, S., Kuroki, T., Toyoshima, K., Rikimaru, K., Nomura, N., Ishizaki, R., Pastan, I., et al. 1986. High incidence of amplification of the epidermal growth factor receptor gene in human squamous carcinoma cell lines. Cancer Res. 46:414–416.
Korc, M., Meltzer, P., Trent, J. 1986. Enhanced expression of epidermal growth factor receptor correlates with alterations of chromosome 7 in human pancreatic cancer. Proc. Natl. Acad. Sci. U.S.A. 83:5141–5144.
Lacroix, H., Iglehart, J.D., Skinner, M.A., Kraus, M.H. (1989) Overexpression of erbB-2 or EGF receptor proteins present in early stage mammary carcinoma is detected simultaneously in matched primary tumors and regional metastases. Oncogene 4:145–151.
Derynck, R., Goeddel, D.V., Ullrich, A., Gutterman, J.U., Williams, R.D., Bringman, T.S., Berger, W.H. (1987) Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors. Cancer Res. 47:707–712.
Di Marco, E., Pierce, J.H., Fleming, T.P., Kraus, M.H., Molloy, C.J., Aaronson, S.A., Di Fiore, P.P. (1989) Autocrine interaction between TGF alpha and the EGF-receptor: Quantitative requirements for induction of the malignant phenotype. Oncogene 4:831–838.
Kraus, M.H., Popescu, N.C., Amsbaugh, S.C., King, C.R. (1987) Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms. Embo. J. 6:605–610.
Kraus, M.H., Yuasa, Y., Aaronson, S.A. (1984) A position 12-activated H-ras oncogene in all HS578T mammary carcinosarcoma cells but not normal mammary cells of the same patient. Proc. Natl. Acad. Sci. U.S.A. 81:5384–5388.
Lemoine, N.R., Staddon, S., Dickson, C., Barnes, D.M., Gullick, W.J. (1990) Absence of activating transmembrane mutations in the c-erbB-2 proto-oncogene in human breast cancer. Oncogene 5:237–239.
Slamon, D.J., Clark, G.M., Wong, S.G., Levin, W.J., Ullrich, A., McGuire, W.L. (1987) Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/ neu oncogene. Science 235:177–182.
van de Vijver, M., van de Bersselaar, R., Devilee, P., Cornelisse, C., Peterse, J., Nusse, R. (1987) Amplification of the neu (c-erbB-2) oncogene in human mammary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene. Mol. Cell. Biol. 7:2019–2023.
Berger, M.S., Locher, G.W., Saurer, S., Gullick, W.J., Waterfield, M.D., Groner, B., Hynes, N.E. (1988) Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. Cancer Res. 48:1238–1243.
Slamon, D.J., Godolphin, W., Jones, L.A., Holt, J.A., Wong, S.G., Keith, D.E., Levin, W.J., Stuart, S.G., Udove, J., Ullrich, A., and et al. (1989) Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244:707–712.
Yokota, J., Yamamoto, T., Toyoshima, K., Terada, M., Sugimura, T., Battifora, H., Cline, M.J. (1986) Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo. Lancet. 1:765–767.
Kern, J.A., Schwartz, D.A., Nordberg, J.E., Weiner, D.B., Greene, M.I., Torney, L., Robinson, R.A. (1990) p185neu expression in human lung adenocarcinomas predicts shortened survival. Cancer Res. 50:5184–5187.
Maguire, H.J., Greene, M.I. (1989) The nue (c-erbB-2) oncogene. Semin. Oncol. 16:148–155.
Tal, M., Wetzler, M., Josefberg, Z., Deutch, A., Gutman, M., Assaf, D., Kris, R., Shiloh, Y., Givol, D., Schlessinger, J. (1988) Sporadic amplification of the HER2/neu protooncogene in adenocarcinomas of various tissues. Cancer Res. 48:1517–1520.
Park, J.B., Rhim, J.S., Park, S.C., Kimm, S.W., Kraus, M.H. (1989) Amplification, overexpression, and rearrangement of the erbB-2 protooncogene in primary human stomach carcinomas. Cancer Res. 49:6605–6609.
Di Fiore, P.P., Pierce, J.H., Kraus, M.H., Segatto, O., King, C.R., Aaronson, S.A. (1987) erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. Science 237:178–182.
Di Fiore, P.P., Pierce, J.H., Fleming, T.P., Hazan, R., Ullrich, A., King, C.R., Schlessinger, J., Aaronson, S.A. (1987) Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells. Cell. 51:1063–1070.
Hudziak, R.M., Schlessinger, J., Ullrich, A. (1987) Increased expression of the putative growth factor receptor p185 HER2 causes transformation and tumorigenesis of NIH 3T3 cells. Proc. Natl. Acad. Sci. U.S.A. 84:7159–7163.
Velu, T.J., Beguinot, L., Vass, W.C., Willingham, M.C., Merlino, G.T., Pastan, I., Lowy, D.R. (1987) Epidermal-growth-factor-dependent transformation by a human EGF receptor proto-oncogene. Science 238:1408–1410.
Riedel, H., Massoglia, S., Schlessinger, J., Ullrich, A. (1988) Ligand activation of overexpressed epidermal growth factor receptors transforms NIH 3T3 mouse fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 85:1477–1481.
Bargmann, C.I., Weinberg, R.A. (1988) Oncogenic activation of the neu-encoded receptor protein by point mutation and deletion. Embo. J. 7:2043–2052.
De Larco, J.E., Todaro, G.J. (1978) Growth factors from murine sarcoma virustransformed cells. Proc. Natl. Acad. Sci. U.S.A. 75:4001–4005.
Finzi, E., Fleming, T., Segatto, O., Pennington, C.Y., Bringman, T.S., Derynck, R., Aaronson, S.A. (1987) The human transforming growth factor type alpha coding sequence is not a direct-acting oncogene when overexpressed in NIH 3T3 cells. Proc. Natl. Acad. Sci. U.S.A. 84:3733–3737.
Lonardo, F., Di Marco, E., King, C.R., Pierce, J.H., Segatto, O., Aaronson, S.A., Di Fiore, P.P. (1990) The normal erbB-2 product is an atypical receptor-like tyrosine kinase with constitutive activity in the absence of ligand. New Biol. 2:992–1003.
Segatto, O., Lonardo, F., Pierce, J.H., Bottaro, D.P., Di Fiore, P.P. (1990) The role of autophosphorylation in modulation of erbB-2 transforming function. New Biol. 2:187–195.
Weiner, D.B., Kokai, Y., Wada, T., Cohen, J.A., Williams, W.V., Greene, M.I. (1989) Linkage of tyrosine kinase activity with transforming ability of the p185neu oncoprotein. Oncogene. 4:1175–1183.
Di Fiore, P., Segatto, O., Lonardo, F., Fazioli, F., Pierce, J.H., Aaronson, S.A. (1990) The carboxy-terminal domains of erbB-2 and epidermal growth factor receptor exert different regulatory effects on instrinsic receptor tyrosine kinase function and transforming activity. Mol. Cell. Biol. 10:2749–2756.
Pierce, J.H., Ruggiero, M., Fleming, T.P., Di, F.P., Greenberger, J.S., Varticovski, L., Schlessinger, J., Rovera, G., Aaronson, S.A. (1988) Signal transduction through the EGF receptor transfected in IL-3-dependent hematopoietic cells. Science 239:628–631.
Di Fiore, P., Segatto, O., Taylor. W.G., Aaronson, S.A., Pierce, J.H. (1990) EGF receptor and erbB-2 tyrosine kinase domains confer cell specificity for mitogenic signaling. Science 248:79–83.
Segatto, O., King, C.R., Pierce, J.H., Di Fiore, P.P., Aaronson, S.A. (1988) Different structural alterations upregulate in vitro tyrosine kinase activity and transforming potency of the erbB-2 gene. Mol. Cell. Biol. 8:5570–5574.
Segatto, O., Lonardo, F., Wexler, D., Fazioli, F., Pierce, J.H., Bottaro, D.P., White, M.F., Di Fiore, P.P. (1991) The juxtamembrane regions of the EGF receptor and gp185erb-2 determine the specificity of signal transduction. Mol. Cell. Biol. in press.
King, C.R., Swain, S.M., Porter, L., Steinberg, S.M., Lippman, M.E., Gelmann, E.P. (1989) Heterogeneous expression of erbB-2 messenger RNA in human breast cancer. Cancer Res. 49:4185–4191.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media New York
About this chapter
Cite this chapter
Di Fiore, P.P., Kraus, M.H. (1991). Mechanisms involving an expanding erbB/EGF receptor family of tyrosine kinases in human neoplasia. In: Dickson, R.B., Lippman, M.E. (eds) Genes, Oncogenes, and Hormones. Cancer Treatment and Research, vol 61. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3500-3_7
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3500-3_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6552-5
Online ISBN: 978-1-4615-3500-3
eBook Packages: Springer Book Archive